Sub-theme: Research and diagnostics
Danaher is a diversified business that designs, manufactures and sells laboratory equipment, consumables and services to clinical and medical laboratories including microscopes, analytical software and imaging and molecular devices. These tools are used in the development of new drugs and for diagnosing critically ill patients.
Impact Score: 32%
Danaher provides test and measurement equipment for drug R&D, diagnosis, environment testing, food and water testing and academic research. The company’s products have a wide range of positive impacts. However, these may be incremental for example, through speeding up research and development or increasing efficiency and accuracy.
Fundamental Quality: 66%
Danaher has a strong market position as one of two major life science platforms. It has a focused management team and a clear, proven approach to operational improvements (known as the ‘Danaher Business System’). The company has focused its portfolio in recent years on the healthcare sector and has ambitious executive officer performance goals and an improving approach to environmental, social and governance issues.
(per £1m invested in this company FY23)
- Auditor independence
- Director overboarding
- Executive remuneration
- Net Zero Carbon targets
- Sustainability leadership
- Product impact
- Generation of plastics waste from single-use products and packaging
- Use of large amounts of water and chemicals in sterilisation and diagnostics
- Electronic waste at end of life
